• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与糖尿病肾病发展相关的转录组表达谱。

Transcriptome expression profiles associated with diabetic nephropathy development.

机构信息

Department of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.

Department of Endocrinology, Qingdao Municipal Hospital, Qingdao University, Qingdao, 266071, Shandong, China.

出版信息

Mol Cell Biochem. 2022 Jul;477(7):1931-1946. doi: 10.1007/s11010-022-04420-5. Epub 2022 Mar 31.

DOI:10.1007/s11010-022-04420-5
PMID:35357607
Abstract

The objective of this study was to identify different transcriptome expression profiles involved in the pathogenesis of diabetic nephropathy (DN) and to illustrate the diagnostic and therapeutic potential of mRNAs, long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs) in DN progression. The participants were divided into four groups: normoalbuminuria (group DM), microalbuminuria (group A2), macroalbuminuria (group A3) and healthy controls (group N). There were three individuals in each group for sequencing. Transcriptome sequencing analysis was performed on the peripheral blood of all the participants to identify the differential expression of mRNAs, lncRNAs, and circRNAs between intervention groups and controls. The functional enrichment analysis, the short time-series expression miner (STEM) program, and the miRNA-circRNA-mRNA network were further conducted. To verify the reproducibility of transcriptome sequencing, 10 and 30 blood samples were collected from the control and diseased groups, respectively. Four candidate biomarkers were selected from differentially expressed circRNAs (circ_0005379, circ_0002024, and circ_0000567, and circ_0001017) and their concentrations in the blood were measured using quantitative PCR (qPCR). In the comparison of A2 with N, 549 mRNAs, 1259 lncRNAs, and 12 circRNAs were screened. In the comparison of A3 with N, 1217 mRNAs, 1613 lncRNAs, and 24 circRNAs were screened. Moreover, in the comparison of diabetes mellitus (DM) with N, 948 mRNAs, 1495 lncRNAs, and 25 circRNAs were screened. Functional enrichment analysis showed that differentially expressed mRNAs were related to insulin secretion, insulin resistance, and inflammation, while differentially expressed lncRNAs were mainly associated with crossover junction endodeoxyribonuclease activity. In STEM analysis, a total of 481 mRNAs and 152 differential expression circRNAs showed a significant tendency. The key relationships in the miRNA-circRNA-mRNA network were identified, such as hsa-miR-103a-3p-circ_0005379-PTEN, hsa-miR-497-5p-circ_0002024-IGF1R and hsa-miR-1269a-circ_0000567-SOX6. In addition, qPCR showed consistent results with RNA sequencing. We found that differentially expressed mRNAs, lncRNAs, and circRNAs participated in DN development. Circ_0005379, circ_0002024, and circ_0000567 could be adopted as potential biomarkers for DN.

摘要

本研究旨在鉴定参与糖尿病肾病(DN)发病机制的不同转录组表达谱,并阐明 mRNAs、长链非编码 RNA(lncRNAs)和环状 RNA(circRNAs)在 DN 进展中的诊断和治疗潜力。参与者被分为四组:正常白蛋白尿(组 DM)、微量白蛋白尿(组 A2)、大量白蛋白尿(组 A3)和健康对照组(组 N)。每组有 3 个人进行测序。对所有参与者的外周血进行转录组测序分析,以鉴定干预组与对照组之间 mRNAs、lncRNAs 和 circRNAs 的差异表达。进一步进行功能富集分析、短期时间序列表达 miner(STEM)程序和 miRNA-circRNA-mRNA 网络分析。为了验证转录组测序的重现性,分别从对照组和病变组采集了 10 个和 30 个血液样本。从差异表达的 circRNAs(circ_0005379、circ_0002024 和 circ_0000567 以及 circ_0001017)中选择了四个候选生物标志物,并使用定量 PCR(qPCR)测量了它们在血液中的浓度。在 A2 与 N 的比较中,筛选到 549 个 mRNAs、1259 个 lncRNAs 和 12 个 circRNAs。在 A3 与 N 的比较中,筛选到 1217 个 mRNAs、1613 个 lncRNAs 和 24 个 circRNAs。此外,在糖尿病(DM)与 N 的比较中,筛选到 948 个 mRNAs、1495 个 lncRNAs 和 25 个 circRNAs。功能富集分析表明,差异表达的 mRNAs 与胰岛素分泌、胰岛素抵抗和炎症有关,而差异表达的 lncRNAs 主要与交叉连接末端核酸酶活性有关。在 STEM 分析中,总共筛选到 481 个 mRNAs 和 152 个差异表达的 circRNAs 呈现出显著的趋势。确定了 miRNA-circRNA-mRNA 网络中的关键关系,例如 hsa-miR-103a-3p-circ_0005379-PTEN、hsa-miR-497-5p-circ_0002024-IGF1R 和 hsa-miR-1269a-circ_0000567-SOX6。此外,qPCR 结果与 RNA 测序结果一致。我们发现,差异表达的 mRNAs、lncRNAs 和 circRNAs 参与了 DN 的发展。circ_0005379、circ_0002024 和 circ_0000567 可以作为 DN 的潜在生物标志物。

相似文献

1
Transcriptome expression profiles associated with diabetic nephropathy development.与糖尿病肾病发展相关的转录组表达谱。
Mol Cell Biochem. 2022 Jul;477(7):1931-1946. doi: 10.1007/s11010-022-04420-5. Epub 2022 Mar 31.
2
CircRNA, lncRNA, and mRNA profiles of umbilical cord blood exosomes from preterm newborns showing bronchopulmonary dysplasia.早产儿支气管肺发育不良患儿脐血外泌体中 circRNA、lncRNA 和 mRNA 谱。
Eur J Pediatr. 2022 Sep;181(9):3345-3365. doi: 10.1007/s00431-022-04544-2. Epub 2022 Jul 5.
3
Identification of potential biomarkers and pathways associated with carotid atherosclerotic plaques in type 2 diabetes mellitus: A transcriptomics study.基于转录组学研究鉴定 2 型糖尿病颈动脉粥样硬化斑块相关的潜在生物标志物和通路。
Front Endocrinol (Lausanne). 2022 Sep 16;13:981100. doi: 10.3389/fendo.2022.981100. eCollection 2022.
4
Transcriptome Sequencing of lncRNAs, circRNAs, miRNAs, mRNAs, and Interaction Network Constructing in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.特发性肺纤维化急性加重中转录组测序:lncRNAs、circRNAs、miRNAs、mRNAs 及相互作用网络构建。
Discov Med. 2023 Oct;35(178):887-896. doi: 10.24976/Discov.Med.202335178.84.
5
Analyses of circRNA and mRNA Profiles in Vogt-Koyanagi-Harada Disease.Vogt-Koyanagi-Harada 病的 circRNA 和 mRNA 谱分析。
Front Immunol. 2021 Dec 22;12:738760. doi: 10.3389/fimmu.2021.738760. eCollection 2021.
6
Whole Transcriptome Sequencing Identified CircRNA Profiles and the Related Networks in Schizophrenia.全转录组测序鉴定精神分裂症中的 circRNA 图谱及相关网络。
J Mol Neurosci. 2022 Aug;72(8):1622-1635. doi: 10.1007/s12031-022-02013-x. Epub 2022 May 11.
7
Whole Transcriptome RNA Sequencing Identified circ_022743, circ_052666, and circ_004452 Were Associated with Colon Cancer Development.全转录组 RNA 测序鉴定 circ_022743、circ_052666 和 circ_004452 与结肠癌发展相关。
DNA Cell Biol. 2020 Oct;39(10):1825-1837. doi: 10.1089/dna.2019.5320. Epub 2020 Aug 14.
8
Construction of the circRNA-miRNA-mRNA Regulatory Network of an Abdominal Aortic Aneurysm to Explore Its Potential Pathogenesis.构建腹主动脉瘤的 circRNA-miRNA-mRNA 调控网络,探索其潜在的发病机制。
Dis Markers. 2021 Nov 5;2021:9916881. doi: 10.1155/2021/9916881. eCollection 2021.
9
Next-Generation Sequencing of Circular RNAs Reveals the Molecular Mechanisms of Chondrogenic Differentiation in Human Adipose-derived Stem Cells.环状RNA的下一代测序揭示了人脂肪干细胞成软骨分化的分子机制。
Cell Biochem Biophys. 2022 Jun;80(2):443-455. doi: 10.1007/s12013-022-01062-8. Epub 2022 Mar 7.
10
Integrative analyses of whole-transcriptome sequencing reveals CeRNA regulatory network in pulmonary hypertension treated with FGF21.全转录组测序的综合分析揭示了 FGF21 治疗肺动脉高压中的 ceRNA 调控网络。
Int Immunopharmacol. 2024 May 10;132:111925. doi: 10.1016/j.intimp.2024.111925. Epub 2024 Apr 4.

引用本文的文献

1
Targeting LINC02544/miR-497-5p/CAPRIN1 axis via exosome-based siRNA to overcome immunotherapy resistance in triple-negative breast cancer.通过基于外泌体的小干扰RNA靶向LINC02544/miR-497-5p/CAPRIN1轴以克服三阴性乳腺癌的免疫治疗耐药性。
Mol Med. 2025 Aug 16;31(1):278. doi: 10.1186/s10020-025-01336-w.
2
Upregulation of circGDI2 inhibits tumorigenesis by stabilizing the expression of RNA m6A demethylase FTO in oral squamous cell carcinoma.环状GDI2的上调通过稳定口腔鳞状细胞癌中RNA m6A去甲基化酶FTO的表达来抑制肿瘤发生。
Noncoding RNA Res. 2024 Aug 9;10:140-152. doi: 10.1016/j.ncrna.2024.08.001. eCollection 2025 Feb.
3

本文引用的文献

1
LncRNA SOX2OT alleviates mesangial cell proliferation and fibrosis in diabetic nephropathy via Akt/mTOR-mediated autophagy.长链非编码 RNA SOX2OT 通过 Akt/mTOR 介导的自噬减轻糖尿病肾病系膜细胞增殖和纤维化。
Mol Med. 2021 Jul 8;27(1):71. doi: 10.1186/s10020-021-00310-6.
2
LncRNA MALAT1/microRNA let-7f/KLF5 axis regulates podocyte injury in diabetic nephropathy.长链非编码 RNA MALAT1/微小 RNA let-7f/KLF5 轴调控糖尿病肾病足细胞损伤。
Life Sci. 2021 Feb 1;266:118794. doi: 10.1016/j.lfs.2020.118794. Epub 2020 Nov 21.
3
circRNA_010383 Acts as a Sponge for miR-135a and its Downregulated Expression Contributes to Renal Fibrosis in Diabetic Nephropathy.
Integrative analyses of biomarkers and pathways for diabetic nephropathy.
糖尿病肾病生物标志物和信号通路的综合分析
Front Genet. 2023 Apr 11;14:1128136. doi: 10.3389/fgene.2023.1128136. eCollection 2023.
4
An integrated RNA sequencing and network pharmacology approach reveals the molecular mechanism of dapagliflozin in the treatment of diabetic nephropathy.一种整合 RNA 测序和网络药理学方法揭示达格列净治疗糖尿病肾病的分子机制。
Front Endocrinol (Lausanne). 2022 Sep 21;13:967822. doi: 10.3389/fendo.2022.967822. eCollection 2022.
环状RNA_010383作为miR-135a的海绵,其表达下调促进糖尿病肾病肾纤维化。
Diabetes. 2020 Nov 17. doi: 10.2337/db200203.
4
Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy.非编码 RNA 在糖尿病肾病中的作用:发病机制、生物标志物和治疗策略。
J Diabetes Res. 2020 Jun 19;2020:3960857. doi: 10.1155/2020/3960857. eCollection 2020.
5
Circ-AKT3 inhibits the accumulation of extracellular matrix of mesangial cells in diabetic nephropathy via modulating miR-296-3p/E-cadherin signals.环状 AKT3 通过调节 miR-296-3p/E-钙黏蛋白信号抑制糖尿病肾病系膜细胞细胞外基质的积累。
J Cell Mol Med. 2020 Aug;24(15):8779-8788. doi: 10.1111/jcmm.15513. Epub 2020 Jun 28.
6
Circular RNA in renal diseases.环状 RNA 在肾脏疾病中的作用。
J Cell Mol Med. 2020 Jun;24(12):6523-6533. doi: 10.1111/jcmm.15295. Epub 2020 Apr 25.
7
miRNA‑342 suppresses renal interstitial fibrosis in diabetic nephropathy by targeting SOX6.miRNA-342 通过靶向 SOX6 抑制糖尿病肾病肾间质纤维化。
Int J Mol Med. 2020 Jan;45(1):45-52. doi: 10.3892/ijmm.2019.4388. Epub 2019 Oct 31.
8
Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis.循环 miR-103a-3p 通过 SNRK/NF-κB/p65 调节轴促进血管紧张素 II 诱导的肾脏炎症和纤维化。
Nat Commun. 2019 May 13;10(1):2145. doi: 10.1038/s41467-019-10116-0.
9
Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-β1.环状 RNA circRNA_15698 通过 miR-185/TGF-β1 加重糖尿病肾病系膜细胞的细胞外基质。
J Cell Physiol. 2019 Feb;234(2):1469-1476. doi: 10.1002/jcp.26959. Epub 2018 Jul 27.
10
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease.糖尿病相关的慢性肾脏病:糖尿病性肾脏疾病与非糖尿病性肾脏疾病。
Nat Rev Nephrol. 2018 Jun;14(6):361-377. doi: 10.1038/s41581-018-0001-y.